A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
Hong Yang,
Muhammad Arif,
Meng Yuan,
Xiangyu Li,
Koeun Shong,
Hasan Türkez,
Jens Nielsen,
Mathias Uhlén,
Jan Borén,
Cheng Zhang,
Adil Mardinoglu
Affiliations
Hong Yang
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Muhammad Arif
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Meng Yuan
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Xiangyu Li
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Koeun Shong
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Hasan Türkez
Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey
Jens Nielsen
Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Gothenburg, Sweden; BioInnovation Institute, 2200 Copenhagen, Denmark
Mathias Uhlén
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
Jan Borén
Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
Cheng Zhang
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Corresponding author
Adil Mardinoglu
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, UK; Corresponding author
Summary: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide. We performed network analysis to investigate the dysregulated biological processes in the disease progression and revealed the molecular mechanism underlying NAFLD. Based on network analysis, we identified a highly conserved disease-associated gene module across three different NAFLD cohorts and highlighted the predominant role of key transcriptional regulators associated with lipid and cholesterol metabolism. In addition, we revealed the detailed metabolic differences between heterogeneous NAFLD patients through integrative systems analysis of transcriptomic data and liver-specific genome-scale metabolic model. Furthermore, we identified transcription factors (TFs), including SREBF2, HNF4A, SREBF1, YY1, and KLF13, showing regulation of hepatic expression of genes in the NAFLD-associated modules and validated the TFs using data generated from a mouse NAFLD model. In conclusion, our integrative analysis facilitates the understanding of the regulatory mechanism of these perturbed TFs and their associated biological processes.